Task: Answer the multiple-choice question.
Question: Which compound exhibits a 11.541\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCCn1nc(Oc2nc(N(C)C)nc(N(C)C)n2)ccc1=O
(b) CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl
Answer: a. CCCn1nc(Oc2nc(N(C)C)nc(N(C)C)n2)ccc1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1nc(Oc2nc(N(C)C)nc(N(C)C)n2)ccc1=O
CCCn1nc(Oc2nc(N(C)C)nc(N(C)C)n2)ccc1=O
6-[[4,6-bis(dimethylamino)-1,3,5-triazin-2-yl]oxy]-2-propylpyridazin-3-one